Shanghai Haohai Biological Technology Co. Ltd Cash Flow-to-Debt Ratio
Shanghai Haohai Biological Technology Co. Ltd cash flow-to-debt ratio. Shanghai Haohai Biological Technology Co. Ltd (5HB) has a Cash Flow-to-Debt Ratio of 0.12x as of June 2023, meaning its operating cash flow of €141.99 Million could theoretically repay 0% of its total liabilities (€1.16 Billion) in one year. Check Shanghai Haohai Biological Technology Co cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Shanghai Haohai Biological Technology Co. Ltd (2016–2025)
Cash flow-to-debt ratio of Shanghai Haohai Biological Technology Co. Ltd from 2016 to 2025. Historical debt coverage capacity for Shanghai Haohai Biological Technology Co. Ltd across 10 annual periods. Check 5HB cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Shanghai Haohai Biological Technology Co. Ltd Cash Flow-to-Debt Ratio by Year (2016–2025)
Shanghai Haohai Biological Technology Co. Ltd cash flow-to-debt ratio by year from 2016 to 2025. Year-by-year debt coverage analysis for Shanghai Haohai Biological Technology Co. Ltd. For the full cash flow conversion analysis, see 5HB cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.44x | €490.97 Million | €1.12 Billion | ▼ -18.3% |
| 2024 | 0.54x | €648.57 Million | €1.20 Billion | ▼ -7.6% |
| 2023 | 0.58x | €634.45 Million | €1.09 Billion | ▲ +149.6% |
| 2022 | 0.23x | €231.30 Million | €990.02 Million | ▼ -39.2% |
| 2021 | 0.38x | €342.29 Million | €890.07 Million | ▼ -17.2% |
| 2020 | 0.46x | €262.07 Million | €564.46 Million | ▼ -33.7% |
| 2019 | 0.70x | €348.91 Million | €498.52 Million | ▲ +7.5% |
| 2018 | 0.65x | €391.28 Million | €600.90 Million | ▲ +34.5% |
| 2017 | 0.48x | €343.06 Million | €708.59 Million | ▲ +34.6% |
| 2016 | 0.36x | €254.49 Million | €707.55 Million | — |